Treating Prostate Cancer With Hormone Therapy Everyday Health MenuNewslettersSearch Prostate Cancer Treating Prostate Cancer With Hormone Therapy By Julia CalifanoMedically Reviewed by Thomas Urban Marron, MD, PhDReviewed: April 27, 2020Medically ReviewedHormone therapy has a variety of uses when treating prostate cancer.iStockHormone therapy, also known as androgen deprivation therapy (ADT), has long been the backbone of treatment for metastatic prostate cancer. The male sex hormone testosterone (a type of hormone known as an androgen) is known to stimulate the growth of prostate cancer cells. Hormone therapy, depending on the form, reduces this effect by either decreasing the body's production of testosterone or blocking testosterone from binding to cancer cells. (1) There are several scenarios in which hormone therapy is typically used:When prostate cancer has spread too far to be cured by surgery or radiation, or has recurred after surgical or radiation treatmentAs an initial treatment (along with radiation therapy) for patients who are at higher risk of recurrence after treatment, such as those with a high PSA (prostate-specific antigen) level or a high Gleason score (a grade, based on an evaluation of a tissue biopsy of the tumor, that suggests how aggressive a case of prostate cancer is) (2)For patients who have a high PSA level following surgery or radiation, even if they have no evidence of disease. Not all doctors, however, agree with this approach (see “What to Consider About Hormone Therapy”) Types of Hormone Therapy for Prostate Cancer “The overwhelming majority of patients get androgen deprivation by way of medical therapy,” explains Moshe Ornstein, MD, a genitourinary medical oncologist at Cleveland Clinic Cancer Center. Doctors use several types of medication to lower testosterone levels, but these therapies do so only temporarily. When you stop taking them, testosterone levels begin to rise again. Here are some of the most commonly used hormone therapies. Luteinizing hormone-releasing hormone (LHRH) agonists and antagonists LHRH is one of the key hormones released by the body before testosterone is produced. LHRH agonists and antagonists lower testosterone levels by blocking the release of LHRH. Treatment with these drugs is sometimes called medical castration because they lower androgen levels as much as orchiectomy, or removal of the testicles, does. (2) LHRH agonists and antagonists include:Lupron, Eligard (leuprolide)Zoladex (goserelin)Trelstar (triptorelin)Vantas (histrelin)Firmagon (degarelix) CYP17 inhibitors An LHRH agonist or antagonist can stop the testicles from making androgens, but other cells in the body (including prostate cancer cells) still make small amounts of androgens. These small amounts of hormones can continue to stimulate cancer growth. A newer medication, Zytiga (abiraterone), blocks a key enzyme involved in androgen production called the CYP17 enzyme. Zytiga can be used to treat metastatic prostate cancer that has become resistant to traditional hormone therapies. (3) Anti-androgens For most prostate cancer cells to grow, androgens have to attach to a protein in the prostate cancer cell called an androgen receptor. Anti-androgens are drugs that also connect to these receptors. "The testosterone can’t hit its target because there is something already there,” explains Mark Pomerantz, MD, a medical oncologist at the Dana-Farber Cancer Institute in Boston. Traditional anti-androgens may be given along with LHRH agonists and antagonists. They include:Eulexin (flutamide)Casodex (bicalutamide)Nilandron (nilutamide) Doctors now have access to a newer type of anti-androgen that interferes with androgen function even more effectively. “These newer agents bind to the androgen receptor much more tightly and also seem to break up the androgen receptor,” explains Dr. Pomerantz. They may be used along with an LHRH agonist or antagonist as a first-line hormonal therapy or added later if traditional hormone treatments are not working. Next-generation anti-androgens include:Xtandi (enzalutamide)Erleda (apalutamide)Nubeqa (darolutamide) How Effective Is Hormone Therapy at Treating Prostate Cancer While hormone therapy can’t cure your prostate cancer, it can stop or slow the growth of the prostate cancer cells in your body. “Hormone therapy is remarkably effective,” says Dr. Ornstein. “Probably over 90 percent of patients will have a nice drop in their PSA while they are on androgen deprivation therapy. The cancer should not grow or spread, because there is no more fuel,” he explains. In many men, however, some cells gain the ability to grow even in the low-testosterone environment created by hormone therapy. As these hormone therapy-resistant prostate cancer cells continue to multiply, the hormone therapy, not surprisingly, has less and less effect on the growth of the tumor. Prostate cancer that is no longer responding to hormone therapy is referred to as castration-resistant prostate cancer. (4) Fortunately, men with castration-resistant prostate cancer have more options for treatment than ever before. “At that point, we can add something new, such as a newer hormonal agent, chemotherapy, or a different chemotherapy, if you had one up front, or an immunotherapy,” explains Ornstein. RELATED: 9 Myths About Prostate Cancer Biochemical Recurrence and Hormone Therapy Hormone therapy is the standard of care for patients with metastatic prostate cancer, but for patients whose only sign of cancer recurrence is a rising PSA level (known as a biochemical recurrence), the benefits are less clear.Some doctors think that hormone therapy works better if it’s started as soon as possible, even if a man is not having any symptoms. Other doctors feel that, because of the side effects of hormone therapy and the chance that the cancer could become resistant to the therapy, treatment shouldn’t be started until symptoms develop. This issue is being actively studied. (2) What Side Effects Should You Expect From Hormone Therapy Although hormone therapy can be effective at controlling prostate cancer growth, the loss of testosterone has side effects in nearly all men. “Conceptually, it’s like putting men into menopause,” explains Ornstein. The potential effects of testosterone deprivation include:Hot flashesNight sweatsWeight gainFatigueIrritabilityMood changes/depressionDecrease in libidoErectile dysfunctionLoss of muscle massBone thinning (osteoporosis) Many of these side effects can be prevented or treated, according to the American Cancer Society. (2) Hot flashes can often be controlled with certain antidepressants or other drugs, for example. A number of drugs are used to help prevent and treat bone thinning or osteoporosis. Depression can be alleviated with antidepressants and counseling. Exercise can fend off multiple side effects, including fatigue, weight gain, and loss of bone and muscle mass. Editorial Sources and Fact-Checking Prostate Cancer: Systemic Therapies. Memorial Sloan Kettering Cancer Center.Hormone Therapy for Prostate Cancer. American Cancer Society. December 18, 2019.Hormone Therapy for Prostate Cancer. Johns Hopkins Medicine.What Is Hormone Therapy for Prostate Cancer? National Cancer Institute. February 28, 2019.Show LessNEWSLETTERS Sign up for our Men' s Health Newsletter SubscribeBy subscribing you agree to the Terms of Use and Privacy Policy. The Latest in Prostate Cancer Prostate Cancer Symptoms Diagnosis Treatment and MoreBy Laura NewmanSeptember 18, 2022 New Combos of Old Drugs Improve Survival in Patients With Prostate Cancer Day 3 of the European Society for Medical Oncology s 2021 CongressAdd-on Zytiga is expected to become the new standard of care almost immediately. Also, COVID-19 vaccination is safe and effective in people with cancer...By Darcy LewisOctober 5, 2021 5 Ways to Boost Your Quality of Life During Prostate Cancer TreatmentAdd these strategies to your prostate cancer treatment regimen to boost your physical and mental health.By Paul RaeburnJuly 6, 2021 NBC Today Show Cohost Al Roker Diagnosed With Prostate CancerRoker spoke out about screening for this form of cancer, which affects 1 in 6 men overall and is the most commonly diagnosed cancer among Black men.By Don RaufNovember 6, 2020 Everyday Health s Prostate Cancer Awareness Month Twitter Chat Here s What You MissedSeptember is prostate cancer awareness month. To mark it, Everyday Health hosted a Twitter chat with two experts from the Prostate Cancer Foundation. ...By Elizabeth DeVita-RaeburnOctober 20, 2020 Prostate Cancer Screening Recommendations Result in More Prostate Cancer Diagnosed Late Fewer Cases Diagnosed EarlyNew study results suggests that the cost of more conservative screening for prostate cancer may be more men diagnosed at more advanced, difficult to treat...By Shari RoanMay 21, 2020 Chemotherapy and Prostate Cancer A First Choice for Treating Metastatic Prostate CancerOver the past couple of years, chemotherapy has emerged as a first-line therapy to treat prostate cancer that has spread to other parts of the body.By Julia CalifanoApril 27, 2020 Multidisciplinary Prostate Cancer Clinics Improve CareThe clinics allow men to get several opinions on the best way to proceed with treatment for their cancer.By Shari RoanNovember 21, 2019 Nonmetastatic Castration-Resistant Prostate Cancer Two New Treatment Options Have Changed the Way It s ManagedUntil recently, there weren’t any approved therapies for this type of prostate cancer.By Julie MarksDecember 10, 2018 Treating Prostate Cancer How to Prevent Decisional Regret There are lots of ways to treat prostate cancer — but sometimes, that can lead to confusion or even regret.By Howard WolinskyNovember 13, 2018 MORE IN 7 Symptoms of Advanced Prostate Cancer and How to Manage Them Cancer Terms Explained Tests to Diagnose Prostate Cancer